Trisomic and allelic differences influence phenotypic variability during development of Down syndrome mice

Genetics

Volumn 189, Issue 4, 2011, Pages 1487-1495

  Deitz, Samantha L ^a   Roper, Randall J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DYRK1A; PROTEIN RCAN1; REGULATOR PROTEIN; TRANSCRIPTION FACTOR ETS 2; UNCLASSIFIED DRUG;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY SIZE; CRANIOFACIAL MALFORMATION; DOWN SYNDROME; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; MALE; MANDIBLE; MOUSE; NONHUMAN; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; TRISOMY 21;

ALLELES; ANIMALS; BASE SEQUENCE; DISEASE MODELS, ANIMAL; DNA PRIMERS; DOWN SYNDROME; MICE; MICE, INBRED C57BL; PHENOTYPE; POLYMERASE CHAIN REACTION;

EID: 83455197218     PISSN: 00166731     EISSN: 19432631     Source Type: Journal    
DOI: 10.1534/genetics.111.131391     Document Type: Article

References (42)

1. Aldridge, K., R. H. Reeves, L. E. Olson, and J. T. Richtsmeier, 2007 Differential effects of trisomy on brain shape and volume in related aneuploid mouse models. Am. J. Med. Genet. A 143: 1060-1070.
2. Altafaj, X., M. Dierssen, C. Baamonde, E. Marti, J. Visa et al., 2001 Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome. Hum. Mol. Genet. 10: 1915-1923.
3. Arron, J. R., M. M. Winslow, A. Polleri, C. P. Chang, H. Wu et al., 2006 NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441: 595-600.
4. Baek, K. H., A. Zaslavsky, R. C. Lynch, C. Britt, Y. Okada et al., 2009 Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature 459: 1126-1130.
5. Baxter, L. L., T. H. Moran, J. T. Richtsmeier, J. Troncoso, and R. H. Reeves, 2000 Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum. Mol. Genet. 9: 195-202.
6. Belichenko, N. P., P. V. Belichenko, A. M. Kleschevnikov, A. Salehi, R. H. Reeves et al., 2009 The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J. Neurosci. 29: 5938-5948.
7. Blazek, J. D., C. N. Billingsley, A. Newbauer, and R. J. Roper, 2010 Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome. Dev. Dyn. 239: 1645-1653.
8. Christianson, A., C. P. Howson, and B. Modell, 2006 March of Dimes Global Report on Birth Defects: The Hidden Toll of Dying and Disabled Children, pp. 1-98. March of Dimes Birth Defects Foundation, White Plains, NY.
9. Cronk, C., A. C. Crocker, S. M. Pueschel, A. M. Shea, E. Zackai et al., 1988 Growth charts for children with Down syndrome: 1 month to 18 years of age. Pediatrics 81: 102-110.
10. Delabar, J. M., D. Theophile, Z. Rahmani, Z. Chettouh, J. L. Blouin et al., 1993 Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur. J. Hum. Genet. 1: 114-124.
11. Dunlevy, L., M. Bennett, A. Slender, E. Lana-Elola, V. L. Tybulewicz et al., 2010 Down's syndrome-like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse. Cardiovasc. Res. 88: 287-295.
12. Eggermann, T., N. Schonherr, S. Spengler, S. Jager, B. Denecke et al., 2010 Identification of a 21q22 duplication in a Silver- Russell syndrome patient further narrows down the Down syndrome critical region. Am. J. Med. Genet. A 152A: 356-359.
13. Epstein, C. J., 2001 Down syndrome (trisomy 21), pp. 1223-1256 in The Metabolic and Molecular Bases of Inherited Disease, edited by C. R. Scriver, A. L. Beaudet, W. S. Sly, and D. Valle. McGraw- Hill, New York.
14. Escorihuela, R. M., A. Fernandez-Teruel, I. F. Vallina, C. Baamonde, M. A. Lumbreras et al., 1995 A behavioral assessment of Ts65Dn mice: a putative Down syndrome model. Neurosci. Lett. 199: 143-146.
15. Hammerle, B., E. Vera-Samper, S. Speicher, R. Arencibia, S. Martinez et al., 2002 Mnb/Dyrk1A is transiently expressed and asymmetrically segregated in neural progenitor cells at the transition to neurogenic divisions. Dev. Biol. 246: 259-273.
16. Hammerle, B., C. Elizalde, J. Galceran, W. Becker, and F. J. Tejedor, 2003 The MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implications. J. Neural Transm. Suppl: 129-137.
17. Hill, C. A., T. E. Sussan, R. H. Reeves, and J. T. Richtsmeier, 2009 Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic "Down syndrome" mice. Am. J. Med. Genet. A 149A: 2158-2165.
18. Kerstann, K. F., E. Feingold, S. B. Freeman, L. J. Bean, R. Pyatt et al., 2004 Linkage disequilibrium mapping in trisomic populations: analytical approaches and an application to congenital heart defects in Down syndrome. Genet. Epidemiol. 27: 240-251.
19. Korbel, J. O., T. Tirosh-Wagner, A. E. Urban, X. N. Chen, M. Kasowski et al., 2009 The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc. Natl. Acad. Sci. USA 106: 12031-12036.
20. Korenberg, J. R.,H. Kawashima, S. M. Pulst, T. Ikeuchi, N. Ogasawara et al., 1990 Molecular definition of a region of chromosome 21 that causes features of the Down syndrome phenotype. Am. J. Hum. Genet. 47: 236-246.
21. Lorenzi, H. A., and R. H. Reeves, 2006 Hippocampal hypocellularity in the Ts65Dn mouse originates early in development. Brain Res. 1104: 153-159.
22. Lyle, R., F. Bena, S. Gagos, C. Gehrig, G. Lopez et al., 2009 Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur. J. Hum. Genet. 17: 454-466.
23. Maslen, C. L., D. Babcock, S. W. Robinson, L. J. Bean, K. J. Dooley et al., 2006 CRELD1 mutations contribute to the occurrence of cardiac atrioventricular septal defects in Down syndrome. Am. J. Med. Genet. A 140: 2501-2505.
24. Mouton, P. R., 2002 Principles and Practices of Unbiased Stereology: An Introduction for Bioscientists. Johns Hopkins University Press, Baltimore.
25. Olson, L. E., J. T. Richtsmeier, J. Leszl, and R. H. Reeves, 2004a A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science 306: 687-690.
26. Olson, L. E., R. J. Roper, L. L. Baxter, E. J. Carlson, C. J. Epstein et al., 2004b Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes. Dev. Dyn. 230: 581-589.
27. Olson, L. E., R. J. Roper, C. L. Sengstaken, E. A. Peterson, V. Aquino et al., 2007 Trisomy for the Down syndrome "critical region" is necessary but not sufficient for brain phenotypes of trisomic mice. Hum. Mol. Genet. 16: 774-782.
28. Pfaffl, M. W., 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29: e45.
29. Reynolds, L. E., A. R. Watson, M. Baker, T. A. Jones, G. D'Amico et al., 2010 Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome. Nature 465: 813-817.
30. Richtsmeier, J. T., L. L. Baxter, and R. H. Reeves, 2000 Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev. Dyn. 217: 137-145.
31. Richtsmeier, J. T., A. Zumwalt, E. J. Carlson, C. J. Epstein, and R. H. Reeves, 2002 Craniofacial phenotypes in segmentally trisomic mouse models for Down syndrome. Am. J. Med. Genet. 107: 317-324.
32. Roizen, N. J., and D. Patterson, 2003 Down's syndrome. Lancet 361: 1281-1289.
33. Roper, R. J., H. K. St. John, J. Philip, A. Lawler, and R. H. Reeves, 2006 Perinatal loss of Ts65Dn Down syndrome mice. Genetics 172: 437-443.
34. Roper, R. J., J. F. VanHorn, C. C. Cain, and R. H. Reeves, 2009 A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog. Mech. Dev. 126: 212-219.
35. Siarey, R. J., J. Stoll, S. I. Rapoport, and Z. Galdzicki, 1997 Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down syndrome. Neuropharmacology 36: 1549-1554.
36. Sumarsono, S. H., T. J. Wilson, M. J. Tymms, D. J. Venter, C. M. Corrick et al., 1996 Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice. Nature 379: 534-537.
37. Sussan, T. E., A. Yang, F. Li, M. C. Ostrowski, and R. H. Reeves, 2008 Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome. Nature 451: 73-75.
38. Van Cleve, S. N., and W. I. Cohen, 2006 Part I: clinical practice guidelines for children with Down syndrome from birth to 12 years. J. Pediatr. Health Care 20: 47-54.
39. Van Cleve, S. N., S. Cannon, and W. I. Cohen, 2006 Part II: Clinical Practice Guidelines for adolescents and young adults with Down Syndrome: 12 to 21 Years. J. Pediatr. Health Care 20: 198-205.
40. Wechsler, J., M. Greene, M. A. McDevitt, J. Anastasi, J. E. Karp et al., 2002 Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. Nat. Genet. 32: 148-152.
41. Wolvetang, E. J., T. J. Wilson, E. Sanij, J. Busciglio, T. Hatzistavrou et al., 2003 ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway. Hum. Mol. Genet. 12: 247-255.
42. Yu, T., C. Liu, P. Belichenko, S. J. Clapcote, S. Li et al., 2010 Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice. Brain Res. 1366: 162-171.